Cargando…

Ret inhibition decreases growth and metastatic potential of estrogen receptor positive breast cancer cells

We show that elevated levels of Ret receptor are found in different sub-types of human breast cancers and that high Ret correlates with decreased metastasis-free survival. The role of Ret in ER+ breast cancer models was explored combining in vitro and in vivo approaches. Our analyses revealed that l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gattelli, Albana, Nalvarte, Ivan, Boulay, Anne, Roloff, Tim C, Schreiber, Martin, Carragher, Neil, Macleod, Kenneth K, Schlederer, Michaela, Lienhard, Susanne, Kenner, Lukas, Torres-Arzayus, Maria I, Hynes, Nancy E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2013
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3799490/ https://www.ncbi.nlm.nih.gov/pubmed/23868506 http://dx.doi.org/10.1002/emmm.201302625

Ejemplares similares

Aberrant RET expression affects normal mammary gland post-lactation transition, enhancing cancer potential
por: Vallone, Sabrina A., et al.
Publicado: (2022)

Decreased NK-cell tumour immunosurveillance consequent to JAK inhibition enhances metastasis in breast cancer models
por: Bottos, Alessia, et al.
Publicado: (2016)

Memo interacts with c-Src to control Estrogen Receptor alpha sub-cellular localization
por: Frei, Anna, et al.
Publicado: (2016)

Estrogen receptors and the aging brain
por: Maioli, Silvia, et al.
Publicado: (2021)

Genes, Gender, Environment, and Novel Functions of Estrogen Receptor Beta in the Susceptibility to Neurodevelopmental Disorders
por: Varshney, Mukesh, et al.
Publicado: (2017)

Expression of the mRNA stability regulator Tristetraprolin is required for lactation maintenance in the mouse mammary gland
por: Goddio, María Victoria, et al.
Publicado: (2018)

µ-Crystallin Is Associated with Disease Outcome in Head and Neck Squamous Cell Carcinoma
por: Jank, Bernhard J., et al.
Publicado: (2021)

Reliable Quantification of Protein Expression and Cellular Localization in Histological Sections
por: Schlederer, Michaela, et al.
Publicado: (2014)

Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation
por: Schlange, Thomas, et al.
Publicado: (2007)

Protein Expression of Folate Receptor Alpha in Adenoid Cystic Carcinoma of the Head and Neck
por: Schnoell, Julia, et al.
Publicado: (2022)

Precision therapy for RET-altered cancers with RET inhibitors
por: Thein, Kyaw Z., et al.
Publicado: (2021)

RET kinase inhibitors for RET-altered thyroid cancers
por: Vodopivec, Danica M., et al.
Publicado: (2022)

RET signaling pathway and RET inhibitors in human cancer
por: Regua, Angelina T., et al.
Publicado: (2022)

Neutralizing Aptamers from Whole-Cell SELEX Inhibit the RET Receptor Tyrosine Kinase
por: Cerchia, Laura, et al.
Publicado: (2005)

Prognostic Relevance of Thyroid-Hormone-Associated Proteins in Adenoid Cystic Carcinoma of the Head and Neck
por: Schnoell, Julia, et al.
Publicado: (2021)

RET Solvent Front Mutations Mediate Acquired Resistance to Selective RET Inhibition in RET-Driven Malignancies
por: Solomon, Benjamin J., et al.
Publicado: (2020)

Adipocyte STAT5 deficiency promotes adiposity and impairs lipid mobilisation in mice
por: Kaltenecker, Doris, et al.
Publicado: (2016)

Retraction: Neutralizing Aptamers from Whole-Cell SELEX Inhibit the RET Receptor Tyrosine Kinase
por: Cerchia, Laura, et al.
Publicado: (2015)

Ret-dependent and Ret-independent mechanisms of Gfl-induced sensitization
por: Schmutzler, Brian S, et al.
Publicado: (2011)

Selective RET kinase inhibition for patients with RET-altered cancers
por: Subbiah, V, et al.
Publicado: (2018)

Targeting RET–interleukin-6 crosstalk to impair metastatic dissemination in breast cancer
por: Morandi, Andrea, et al.
Publicado: (2014)

Treatment with Angiotensin-(1-7) Prevents Development of Oral Papilloma Induced in K-ras Transgenic Mice
por: Schere-Levy, Carolina, et al.
Publicado: (2022)

Hallmarks of RET and Co-occuring Genomic Alterations in RET-aberrant Cancers
por: Adashek, Jacob J., et al.
Publicado: (2021)

The evolution of RET inhibitor resistance in RET-driven lung and thyroid cancers
por: Rosen, Ezra Y., et al.
Publicado: (2022)

Precision oncology with selective RET inhibitor selpercatinib in RET-rearranged cancers
por: Gouda, Mohamed A., et al.
Publicado: (2023)

Inhibitor repurposing reveals ALK, LTK, FGFR, RET and TRK kinases as the targets of AZD1480
por: Gudernova, Iva, et al.
Publicado: (2017)

Histone Acetyl Transferase 1 Is Essential for Mammalian Development, Genome Stability, and the Processing of Newly Synthesized Histones H3 and H4
por: Nagarajan, Prabakaran, et al.
Publicado: (2013)

The Oncogene AF1Q is Associated with WNT and STAT Signaling and Offers a Novel Independent Prognostic Marker in Patients with Resectable Esophageal Cancer
por: Gruber, Elisabeth S., et al.
Publicado: (2019)

Erratum: Gruber, E.S.; et al. The Oncogene AF1Q is Associated with WNT and STAT Signaling and Offers a Novel Independent Prognostic Marker in Patients with Resectable Esophageal Cancer. Cells 2019, 8, 1357
por: Gruber, Elisabeth S., et al.
Publicado: (2020)

Involvement of RET oncogene in human tumours: specificity of RET activation to thyroid tumours.
por: Santoro, M., et al.
Publicado: (1993)

Response to RET-Specific Therapy in RET Fusion-Positive Anaplastic Thyroid Carcinoma
por: Dias-Santagata, Dora, et al.
Publicado: (2020)

The RET gene encodes RET protein, which triggers intracellular signaling pathways for enteric neurogenesis, and RET mutation results in Hirschsprung's disease
por: Bhattarai, Chacchu, et al.
Publicado: (2022)

miRNA Profiling Reveals Dysregulation of RET and RET-Regulating Pathways in Hirschsprung's Disease
por: Li, Shuangshuang, et al.
Publicado: (2016)

EGF Induced RET Inhibitor Resistance in CCDC6-RET Lung Cancer Cells
por: Chang, Hyun, et al.
Publicado: (2017)

Aggravated pulmonary injury after subarachnoid hemorrhage in PDGF-B(ret/ret) mice
por: Pan, Pengyu, et al.
Publicado: (2020)

Author Correction: The evolution of RET inhibitor resistance in RET-driven lung and thyroid cancers
por: Rosen, Ezra Y., et al.
Publicado: (2022)

Neutralization of Osteopontin Inhibits Obesity-Induced Inflammation and Insulin Resistance
por: Kiefer, Florian W., et al.
Publicado: (2010)

Association between somatic RET mutations and clinical and genetic characteristics in patients with metastatic colorectal cancer
por: Yang, Yuan‐Zhong, et al.
Publicado: (2021)

RET expression and detection of KIF5B/RET gene rearrangements in Japanese lung cancer
por: Sasaki, Hidefumi, et al.
Publicado: (2012)

Clinical development of RET inhibitors in RET-rearranged non-small cell lung cancer: Update
por: Mendoza, Luis
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_tdtfjhoi2kmusfv7f633ap883j